Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor HPV DNA Driven Adjuvant Treatment Deintensification After Transoral Surgery for HPV-Positive Squamous Cell Carcinoma of the Oropharynx

NCT06915038 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT06915038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06915038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor HPV DNA Driven Adjuvant Treatment Deintensification After Transoral Surgery for HPV-Positive Squamous Cell Carcinoma of the Oropharynx
Lead sponsor
Indiana University
Phase
Not applicable
Overall status
Recruiting
Start date
June 11, 2025
Completion date
December 31, 2028
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hpv positive cancer, squamous cell carcinoma of oropharynx, throat cancer, tonsil cancer